[go: up one dir, main page]

DK0506574T3 - Protein med aktivitet af cytokintype, rekombinant-DNA, der koder for dette protein, celler og transformerede mikroorganismer - Google Patents

Protein med aktivitet af cytokintype, rekombinant-DNA, der koder for dette protein, celler og transformerede mikroorganismer

Info

Publication number
DK0506574T3
DK0506574T3 DK92400858.4T DK92400858T DK0506574T3 DK 0506574 T3 DK0506574 T3 DK 0506574T3 DK 92400858 T DK92400858 T DK 92400858T DK 0506574 T3 DK0506574 T3 DK 0506574T3
Authority
DK
Denmark
Prior art keywords
protein
cytokine
cells
type activity
recombinant dna
Prior art date
Application number
DK92400858.4T
Other languages
Danish (da)
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Bouteiller Christine Labit-Le
Pascal En Saint-Pier Leplatois
Marilyn Magazin
Adrian Minty
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DK0506574T3 publication Critical patent/DK0506574T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK92400858.4T 1991-03-29 1992-03-27 Protein med aktivitet af cytokintype, rekombinant-DNA, der koder for dette protein, celler og transformerede mikroorganismer DK0506574T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.

Publications (1)

Publication Number Publication Date
DK0506574T3 true DK0506574T3 (da) 1996-04-09

Family

ID=26228598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92400858.4T DK0506574T3 (da) 1991-03-29 1992-03-27 Protein med aktivitet af cytokintype, rekombinant-DNA, der koder for dette protein, celler og transformerede mikroorganismer

Country Status (14)

Country Link
US (1) US5652123A (ro)
EP (1) EP0506574B1 (ro)
JP (1) JP2865423B2 (ro)
AT (1) ATE130869T1 (ro)
CA (1) CA2083826C (ro)
DE (2) DE506574T1 (ro)
DK (1) DK0506574T3 (ro)
ES (1) ES2054601T3 (ro)
GR (2) GR940300052T1 (ro)
HK (1) HK1007435A1 (ro)
HU (2) HU217099B (ro)
IE (1) IE72165B1 (ro)
MD (1) MD1652G2 (ro)
WO (1) WO1992017586A1 (ro)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
CA2142860A1 (en) * 1992-08-21 1994-03-03 Gregorio Aversa Human interleukin-13
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
EP0809694B1 (en) * 1995-02-10 2005-12-21 Novozymes A/S Bacillus proteases
AU4534796A (en) * 1995-02-10 1996-08-27 Novo Nordisk A/S Bacillus proteases
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
CN1352686A (zh) 1998-12-14 2002-06-05 遗传学院有限公司 细胞因子受体链
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
AU2001253282A1 (en) 2000-04-07 2001-10-23 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) * 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
SG10201404273QA (en) 2003-12-23 2014-10-30 Genentech Inc Novel anti-il 13 antibodies and uses thereof
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
CA2587903A1 (en) 2004-11-17 2006-05-26 Amgen Fremont Inc. Fully human monoclonal antibodies to il-13
WO2006124451A2 (en) * 2005-05-11 2006-11-23 Centocor, Inc. Anti-il-13 antibodies, compositions, methods and uses
WO2007036745A2 (en) 2005-09-30 2007-04-05 Medimmune Limited Interleukin-13 antibody composition
EP3910065A1 (en) * 2006-09-08 2021-11-17 AbbVie Bahamas Ltd. Interleukin -13 binding proteins
CA2685123A1 (en) * 2007-04-23 2008-10-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
AU2009283008A1 (en) * 2008-08-20 2010-02-25 Centocor Ortho Biotech Inc. Engineered anti-IL-13 antibodies, compositions, methods and uses
GB0904214D0 (en) 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) * 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
KR102260855B1 (ko) 2013-09-13 2021-06-04 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
MX382393B (es) 2013-09-13 2025-03-13 Genentech Inc Métodos y composiciones que comprenden polipéptidos recombinantes purificados.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
HU9203753D0 (en) 1993-03-29
MD1652G2 (ro) 2001-12-31
US5652123A (en) 1997-07-29
MD970099A (ro) 1998-04-30
IE921016A1 (en) 1992-10-07
EP0506574A1 (fr) 1992-09-30
GR940300052T1 (en) 1994-08-31
CA2083826A1 (en) 1992-09-30
HK1007435A1 (en) 1999-04-09
GR3019043T3 (en) 1996-05-31
ATE130869T1 (de) 1995-12-15
HU217099B (hu) 1999-11-29
DE69206301D1 (de) 1996-01-11
EP0506574B1 (fr) 1995-11-29
ES2054601T3 (es) 1996-04-01
HUT68162A (en) 1995-05-29
JP2865423B2 (ja) 1999-03-08
WO1992017586A1 (fr) 1992-10-15
DE506574T1 (de) 1994-11-17
ES2054601T1 (es) 1994-08-16
IE72165B1 (en) 1997-03-26
JPH06500567A (ja) 1994-01-20
MD1652F2 (ro) 2001-04-30
CA2083826C (en) 1999-04-27
DE69206301T2 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
DK0506574T3 (da) Protein med aktivitet af cytokintype, rekombinant-DNA, der koder for dette protein, celler og transformerede mikroorganismer
DK0781329T3 (da) Overekspression af mammale og virale proteiner
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ES2093112T3 (es) Nuevo factor neurotrofico.
UA84666C2 (ru) ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН
DE69433107D1 (de) Rekombinante dnase b aus streptococcus pyogenes
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
ATE121754T1 (de) Vakzine gegen bordetella.
EP1501936A4 (en) PROTEIN FAMILY OF CYTOKINE
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
ATE203272T1 (de) Rekombinant dns kodierend für eine endochitinase
CA2253006A1 (en) .beta.-carotene hydroxylase gene
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0369413A3 (en) Interferon-gamma binding proteins
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
AU654155B2 (en) A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
AU5964398A (en) Novel mouse cxc chemokine receptor
WO1999060117A3 (fr) Polypeptide prax-1
EP0953642A4 (en) ANTIGENIC PROTEIN DRAWN FROM THE INFECTIOUS LARYNGO-TRACHEITIS VIRUS